The relevance of Takotsubo cardiomyopathy as a stress-induced disease

The relevance of Takotsubo cardiomyopathy as a stress-induced disease

Автор: Ganych Angelina A., Oflidi Ekaterina K., Zaitseva Anastasia Y., Myasnikova Alla B., Chernik Oksana V.

Журнал: Cardiometry @cardiometry

Рубрика: Original research

Статья в выпуске: 26, 2023 года.

Бесплатный доступ

Takotsubo cardiomyopathy, or Takotsubo syndrome, can be quite rare found, but however the frequency of diagnosing with this disease among patients of cardiology departments is constantly growing. On the one hand, this may be due to improved diagnostics of this pathology, and on the other hand, to an increasing frequency of mental disorders in the human population and the spread of other risk factors, including drug-induced variants. The pathogenesis of the development of Takotsubo cardiomyopathy is associated with an increase in the level of catecholamines, which may be the result of a reactive sympathetic enhancement in response to external factors or be the result of taking antidepressants that can produce a similar effect. Although the diagnostics of this pathology has made significant progress, but however there is still no consensus on the strategy of treatment. This is due to the lack of large-scale randomized prospective studies that could justify one or another therapeutic approach. Basically, the efforts of medical doctors are aimed at maintaining cardiac activity, eliminating the trigger of the disease and at treating complications.

Еще

Takotsubo cardiomyopathy, ejection fraction, ballooning, antidepressants

Короткий адрес: https://sciup.org/148326594

IDR: 148326594   |   DOI: 10.18137/cardiometry.2023.26.105113

Список литературы The relevance of Takotsubo cardiomyopathy as a stress-induced disease

  • Rius Ottenheim N, Pan KY, Kok AAL, Jörg F, Eikelenboom M, Horsfall M, Luteijn RA, van Oppen P, Rhebergen D, Schoevers RA, Penninx BWJH, Giltay EJ. Predictors of mental health deterioration from pre- to post-COVID-19 outbreak. BJPsych Open. 2022(8):e162. doi: 10.1192/bjo.2022.555.
  • Gafiatulina NH, Vorob'ev GA, Shevchenko AM. New loneliness as a factor influencing the social well-being of the Russian society in the context of restrictive measures during the pandemic. Gosudarstvennoe i municipal'noe upravlenie. Uchenye zapiski. 2022(1):223-228. doi: 10.22394/2079-1690-2022-1-1-223-228.
  • Nikiforov SA, Allenov AM., Arestova AA, L'vova DP, Alekhin SG. Mental health and chronic noncommunicable diseases. // Problemy social'noj gigieny, zdravoohraneniya i istorii mediciny. – 2020(28):1252-1258. doi: 10.32687/0869-866X-2020-28-6-1252-1258.
  • Matta A, Delmas C, Campelo-Parada F, Lhermusier T, Bouisset F, Elbaz M, Nader V, Blanco S, Roncalli J, Carrié D. Takotsubo cardiomyopathy. Rev Cardiovasc Med. 2022(23):38. doi: 10.31083/j.rcm2301038.
  • Y-Hassan S, Tornvall P. Epidemiology, pathogenesis, and management of takotsubo syndrome. Clin Auton Res. 2018(28):53-65. doi: 10.1007/s10286-017-0465-z.
  • Deshmukh A, Kumar G, Pant S, Rihal C, Murugiah K, Mehta JL. Prevalence of Takotsubo cardiomyopathy in the United States. 5 American Heart Journal. 2012(164): 66–71.e1. doi: 10.1016/j.ahj.2012.03.020.
  • Barbieri L, Galli F, Conconi B, Gregorini T, Lucreziotti S, Mafrici A, Pravettoni G, Sommaruga M, Carugo S. Takotsubo syndrome in COVID-19 era: Is psychological distress the key? J Psychosom Res. 2021(140):110297. doi: 10.1016/j.jpsychores.2020.110297.
  • Prasad A, Dangas G, Srinivasan M, Yu J, Gersh BJ, Mehran R, Stone GW. Incidence and angiographic characteristics of patients with apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: an analysis from a multicenter, international study of ST-elevation myocardial infarction. Catheterization and Cardiovascular Interventions. 2014(83): 343–348.
  • Rathore SS, Iqbal K, Shafqat S, Tariq E, Tousif S, UlHaq ZG, Fernández-Sánchez D, Hernández-Woodbine MJ, Granados-Mendoza SC, Lacouture-Cárdenas NA, Avendaño-Capriles CA, Maheshwari C, Iqbal A, Mahalwar G, Shariff M, Kumar A. Meta-analysis of incidence and outcomes of life-threatening arrhythmias in takotsubo cardiomyopathy. Indian Heart J. 2022(74):110-119. doi: 10.1016/j.ihj.2022.01.005.
  • Vaccaro A, Despas F, Delmas C, Lairez O, Lambert E, Lambert G, Labrunee M, Guiraud T, Esler M, Galinier M, Senard JM, Pathak A. Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy. PLoS One. 2014(9):e93278. doi: 10.1371/journal.pone.0093278.
  • Kume T, Kawamoto T, Okura H, Toyota E, Neishi Y, Watanabe N, Hayashida A, Okahashi N, Yoshimura Y, Saito K, Nezuo S, Yamada R, Yoshida K. Local release of catecholamines from the hearts of patients with tako-tsubo-like left ventricular dysfunction. Circ J Off J Jpn Circ Soc. 2008(72):106–108. doi: 10.1253/circj.72.106.
  • Nef HM, Möllmann H, Akashi YJ, Hamm CW. Mechanisms of stress (Takotsubo) cardiomyopathy. Nature Reviews. Cardiology. 2010(7):187–193. doi: 10.1038/nrcardio.2010.16.
  • Nef HM, Möllmann H, Troidl C, Kostin S, Voss S, Hilpert P, Behrens CB, Rolf A, Rixe J, Weber M, Hamm CW, Elsässer A. Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. European Heart Journal. 2010(30):2155–2164. doi: 10.1093/eurheartj/ehp240.
  • Rodríguez M, Rzechorzek W, Herzog E, Lüscher TF. Misconceptions and Facts about Takotsubo Syndrome. The American Journal of Medicine. 2019(132):25-31. doi:10.1016/j.amjmed.2018.07.007.
  • Jaguszewski M, Osipova J, Ghadri J, Napp LC, Widera C, Franke J, Fijalkowski M, Nowak R, Fijalkowska M, Volkmann I, Katus HA, Wollert KC, Bauersachs J, Erne P, Lüscher TF, Thum T, Templin C. A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction. European Heart Journal. 2014(35):999–1006. doi: 10.1093/eurheartj/eht392.
  • Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, Francone M, Desch S, Gutberlet M, Strohm O, Schuler G, Schulz-Menger J, Thiele H, Friedrich MG. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) сardiomyopathy. JAMA. 2011(306):277 -286. doi: 10.1001/jama.2011.992.
  • Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Münzel T, Knorr M, Templin C. Long-term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol. 2018(72):874–882. doi: 10.1016/j.jacc.2018.06.016.
  • Boldueva S.A., Evdokimov D.S. Takotsubo cardiomyopathy. Review of literature data: clinical picture, diagnostic algorithm, treatment, prognosis. Part II. Rossijskij kardiologicheskij zhurnal. 2022(27):120-128. doi:10.15829/1560-4071-2022-4994.
  • Barmore W, Patel H, Harrell S, Garcia D, Calkins JB Jr. Takotsubo cardiomyopathy: A comprehensive review. World J Cardiol. 2022(14):355-362. doi: 10.4330/wjc.v14.i6.355.
  • Kumar S, Kaushik S, Nautiyal A, Choudhary SK, Kayastha BL, Mostow N, Lazar JM. Cardiac rupture in takotsubo cardiomyopathy: a systematic review. Clin Cardiol. 2011(34):672–676. doi: 10.1002/clc.20957.
  • Previtali M, Repetto A, Panigada S, Camprotondo R, Tavazzi L. Left ventricular apical ballooning syndrome: prevalence, clinical characteristics and pathogenetic mechanism in a European population. International Journal of Cardiology. 2009(134):91– 96.
  • Kulik VL, Yabluchanskij NI. QT interval in a cardiology clinic. Vestnik Har'kovskogo nacional'nogo universiteta imeni V.N. Karazina. Seriya «Medicina». 2009(18):73-96.
  • Ghadri JR, Cammann VL, Jurisic S, Seifert B, Napp LC, Diekmann J, Bataiosu DR, D'Ascenzo F, Ding KJ, Sarcon A, Kazemian E, Birri T, Ruschitzka F, Lüscher TF, Templin C. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. European Journal of Heart Failure. 2018(19):1036–1042.
  • Cai L, Addetia K, Medvedofsky D, Spencer KT. Myocardial strain may be useful in differentiating Takotsubo cardiomyopathy from left anterior descending coronary artery ischemia. // Int J Cardiol. 2017(230):359-363. doi: 10.1016/j.ijcard.2016.12.104.
  • Heggemann F, Hamm K, Brade J, Streitner F, Doesch C, Papavassiliu T, Borggrefe M, Haghi D. Right ventricular function quantification in Takotsubo cardiomyopathy using two-dimensional strain echocardiography. // PLoS One. 2014(9):e103717. doi: 10.1371/journal.pone.0103717.
  • Vicario MLE, Caso P, Martiniello AR, Fontanella L,Petretta M, Sardu C, Petretta MP, Bonaduce D. Effects of volume loading on strain rate and tissue Doppler velocity imaging in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown). 2006(7):852-8. doi: 10.2459/01.JCM.0000253826.44234.09.
  • Dias A, Franco E, M Rubio, Bhalla V, Pressman GS, Amanullah S, Hebert K, Figueredo VM. Usefulness of left ventricular strain analysis in patients with takotsubo syndrome during acute phase. // Echocardiography. 2018(35):179-183. doi: 10.1111/echo.13762.
  • Kumar S, Waldenborg M, Bhumireddy P, Ramkissoon K, Loiske K, Innasimuthu AL, Grodman RS, Heitner JF, Emilsson K, Lazar JM. Diastolic function improves after resolution of takotsubo cardiomyopathy. // Clin Physiol Funct Imaging. 2016(36):17-24. doi: 10.1111/cpf.12188.
  • Ahmad SA, Brito D, Khalid N, Ibrahim MA. Takotsubo Cardiomyopathy. 2022 Mar 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 28613549.
  • Jensch PJ, Stiermaier T, Eitel I. Takotsubo Syndrome-Is There a Need for CMR? Curr Heart Fail Rep. 2021(18):200-210. doi: 10.1007/s11897-021-00518-x.
  • Ismail TF, Hsu L, Greve AM, Gonçalves C, Jabbour A, Gulati A, Hewins B, Mistry N, Wage R, Roughton M, Ferreira PF, Gatehouse P, Firmin D, O’Hanlon R, Pennell DJ, Prasad SK, Arai AE. Coronary microvascular ischemia in hypertrophic cardiomyopathy a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. Journal of Cardiovascular Magnetic Resonance. 2015(16):49. doi: 10.1186/s12968-014-0049-1.
  • Naruse Y, Sato A, Kasahara K, Makino K, Sano M, Takeuchi Y, Nagasaka S, Wakabayashi Y, Katoh H, Satoh H, Hayashi H, Aonuma K. The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images. Journal of Cardiovascular Magnetic. 2012(13):67. doi: 10.1186/1532-429X-13-67.
  • Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y.-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management. Eur Heart J. 2018;39(22):2047–2062. doi: 10.1093/eurheartj/ehy077.
  • Jeon U, Park S, Park S, Lee EY, Gil HW. Clinical characteristics of stress cardiomyopathy in patients with acute poisoning. Sci Rep. 2018(8):223. doi: 10.1038/s41598-017-18478-5.
  • Ramaraj R, Sorrell VL, Movahed MR. Levels of troponin release can aid in the early exclusion of stress-induced (takotsubo) cardiomyopathy. Experimental and Clinical Cardiology. 2011(14):6–8.
  • Fröhlich GM, Schoch B, Schmid F. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy. Int J Cardiol. 2012(154):328–332. doi: 10.1016/j.ijcard. 2011.09.077.
  • Azouzi A, Omri M, Kraiem H, Mbarek H, Slim M, Boussarsar M. Iatrogenic epinephrine-induced Takotsubo cardiomyopathy in beta-blocker poisoning: case report. Cor et Vasa. 2019(61):e319-322. https://doi.org/10.1016/j.crvasa.2018.06.004.
  • Ward C, Qazi A, Alqasrawi M, Adeola O, Marthaler B. Reverse takotsubo from iatrogenic stress induced cardiomyopathy. J Am Coll Cardiol. 2019(73):2195.
  • Teixeira R, Sousa M, Amorim C, Ribeiro M. Iatrogenic reverse takotsubo cardiomyopathy. Echo Res Pract. 2014(1):I1–I3. doi: 10.1530/ERP-14-0009.
  • Shubnikova E.V., Bukatina T.M., Kaperko D.A., Vel'c N.Yu., Darmstukova M.A., Kazakov A.S., Snegireva I.I., Zhuravleva E.O., Kutekhova G.V. Post-marketing safety studies of medicines: analysis of the recommendations of foreign regulatory authorities. Bezapasnost' i risk farmakoterapii. 2018(6):130-137. https://doi.org/10.30895/2312-7821-2018-6-3-130-137.
  • Elhami N, Engerström L. Venlafaxine was suspected to have triggered life-threatening takotsubo syndrome. Lakartidningen. 2021(4);118:20187.
  • Sancassiani F, Carta MG, Montisci R, Preti A, Machado S, Moro MF, Marchetti MF, Meloni L. Takotsubo Syndrome is Associated with Mood Disorders and Antidepressants Use, not with Anxiety and Impairment of Quality of Life Due to the Psychiatric Disorders. Clin Pract Epidemiol Ment Health. 2018(14):26-32. doi: 10.2174/1745017901814010026.
  • Yu JW, Park J, Song PS, Park JH, Kim MS, Jeon GJ, Kim TO. Two Cases of Stress Cardiomyopathy during Esophagogastroduodenoscopy. Clin Endosc. 2016;49:76–80. doi: 10.5946/ce.2016.49.1.76.
  • Hui Mbbs S, Kwok A, Chan W, Leong Tan K. Takotsubo cardiomyopathy as an adverse event post bronchoscopy. Chest. 2019(156):A1862. doi: https://doi.org/10.1016/j.chest.2019.08.1608.
  • Isogai T, Matsui H, Tanaka H, Fushimi K, Yasunaga H. Early β-blocker use and in-hospital mortality in patients with Takotsubo cardiomyopathy. Heart. 2016(102):1029–1035. doi: 10.1136/heartjnl-2015-308712.
  • Kim H, Senecal C, Lewis B, Prasad A, Rajiv G, Lerman LO, Lerman A. Natural history and predictors of mortality of patients with Takotsubo syndrome. Int J Cardiol. 2018(267):22–27. doi: 10.1016/j.ijcard. 2018.04.139.
  • Zvonarev V. Takotsubo Cardiomyopathy: Medical and Psychiatric Aspects. Role of Psychotropic Medicationsin the Treatment of Adults with "Broken Heart" Syndrome. Cureus. 2019(11):e5177. doi: 10.7759/cureus.5177.
  • Dias A, Franco E, Figueredo VM., Hebert K, Quevedo HC. Occurrence of Takotsubo cardiomyopathy and use of antidepressants. International Journal of Cardiology. 2014(174):433–436. doi:10.1016/j.ijcard.2014.04.028.
  • Vasudev R, Rampal U, Patel H, Patel K, Bikkina M, Shamoon F. Selective serotonin-norepinephrine reuptake inhibitors-induced takotsubo cardiomyopathy. N Am J Med Sci. 2016;8:312–315. DOI: 10.4103/1947-2714.187153.
  • De Roock S, Beauloye C, De Bauwer I, Gurne O, Gerber B, Hantson P. Tako-tsubo syndrome following nortriptyline overdose. Clin Toxicol (Phila) 2008(46):475–478. doi: 10.1080/15563650701519786.
  • Kitami M, Oizumi H, Kish S, Furukawa Y. Takotsubo cardiomyopathy associated with lithium intoxication in bipolar disorder: a case report. J Clin Psychopharmacol. 2014(34):410–411. doi: 10.1097/JCP.0b013e3182a95a27.
  • Ziegelstein, RC. (2010). Depression and Tako-Tsubo Cardiomyopathy. The American Journal of Cardiology. 2010(105):281–282. doi:10.1016/j.amjcard.2009.09.002.
  • Akashi YJ. Long-term prognosis in patients with Takotsubo syndrome. Eur J Heart Fail. 2019(6):790-791. doi: 10.1002/ejhf.1417.
Еще
Статья научная
SciUp 2024 © 2024 ©